Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature-Reference-Cited by-同舟云学术

Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature

Published:2020-09 Issue:9 Volume:19 Page:102620
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Urban Maria Letizia,Bettiol Alessandra,Serena Caterina,Comito Chiara,Turrini Irene,Fruttuoso Silvia,Silvestri Elena,Vannacci Alfredo,Ravaldi Claudia,Petraglia Felice,Emmi Giacomo,Prisco Domenico,Mecacci Federico

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. Antiphospholipid syndrome;Cervera;Thromb Res,2017

2. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome;Andreoli;Ann Rheum Dis,2017

3. Obstetric antiphospholipid syndrome;Galarza-Maldonado;Autoimmun Rev,2012

4. Neonatal outcome in pregnant patients with antiphospholipid syndrome;Jeremic;J Perinat Med,2015

5. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study;Bouvier;Blood,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preeclampsia and the Antiphospholipid Syndrome;Biomedicines;2023-08-18

2. Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature;Frontiers in Pharmacology;2022-05-19

3. Antiphospholipid Antibodies Increase the Risk of Fetal Growth Restriction: A Systematic Meta-Analysis;International Journal of Clinical Practice;2022-01-31

4. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review;Journal of Clinical Medicine;2022-01-28

5. Antiphospholipid syndrome and recurrent pregnancy losses;Immunology of Recurrent Pregnancy Loss and Implantation Failure;2022